Previous Article | Next Article 
Journal of Virology, September 2001, p. 8289-8297, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.8289-8297.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Structure-Based Mutational Analysis of the
Hepatitis C Virus NS3 Helicase
Chun-Ling
Tai,1
Wen-Ching
Pan,1
Shwu-Huey
Liaw,2
Ueng-Cheng
Yang,3
Lih-Hwa
Hwang,1,4,* and
Ding-Shinn
Chen4
Graduate Institute of Microbiology, National Taiwan
University,1 Department of Life
Science2 and Institute of
Biochemistry,3 National Yang Ming University,
and Hepatitis Research Center, National Taiwan University
Hospital,4 Taipei, Taiwan
Received 2 January 2001/Accepted 11 May 2001
 |
ABSTRACT |
The carboxyl terminus of the hepatitis C virus (HCV) nonstructural
protein 3 (NS3) possesses ATP-dependent RNA helicase activity. Based on
the conserved sequence motifs and the crystal structures of the
helicase domain, 17 mutants of the HCV NS3 helicase were generated. The
ATP hydrolysis, RNA binding, and RNA unwinding activities of the mutant
proteins were examined in vitro to determine the functional role of the
mutated residues. The data revealed that Lys-210 in the Walker A motif
and Asp-290, Glu-291, and His-293 in the Walker B motif were crucial to
ATPase activity and that Thr-322 and Thr-324 in motif III and Arg-461
in motif VI significantly influenced ATPase activity. When the pairing
between His-293 and Gln-460, referred to as gatekeepers, was replaced
with the Asp-293/His-460 pair, which makes the NS3 helicase more like
the DEAD helicase subgroup, ATPase activity was not restored. It thus
indicated that the whole microenvironment surrounding the gatekeepers,
rather than the residues per se, was important to the enzymatic
activities. Arg-461 and Trp-501 are important residues for RNA binding,
while Val-432 may only play a coadjutant role. The data demonstrated that RNA helicase activity was possibly abolished by the loss of ATPase
activity or by reduced RNA binding activity. Nevertheless, a low
threshold level of ATPase activity was found sufficient for helicase
activity. Results in this study provide a valuable reference for
efforts under way to develop anti-HCV therapeutic drugs targeting NS3.
 |
INTRODUCTION |
Hepatitis C virus (HCV) is the major
causative agent of parenterally transmitted non-A, non-B hepatitis
(6, 8, 25). The infection easily becomes persistent and
causes chronic hepatitis (17), which may lead to liver
cirrhosis (38, 42) and hepatocellular carcinoma (9,
36). Alpha interferon and ribavirin combination therapy is the
only effective therapy for chronic hepatitis C; however, less than 50%
of patients respond to the treatment (2, 3, 5, 28).
Therefore, new, more effective treatments for hepatitis C urgently need
to be developed.
The HCV genome encodes a large polyprotein comprised of 3,008 to 3,037 amino acids (aa) (4). Nonstructural protein 3 (NS3) of
HCV, ranging from aa 1027 to 1657 of the polyprotein, is a multifunctional protein. The N terminus of NS3 expresses a serine protease (27), while two-thirds of the C- terminal region
of the protein expresses an RNA helicase (18, 20, 40, 41). The homologous NS3s in all flaviviruses and pestiviruses sequenced to
date contain conserved sequence motifs (31), suggesting
that the enzyme may be important in viral replication and may be a potential target for developing antiviral drugs.
Helicases are the enzymes that unwind duplex DNA or RNA at the expense
of energy derived from nucleoside triphosphate (NTP) hydrolysis
(13). A large number of putative RNA and DNA helicases from different organisms have been identified (14, 23).
Sequence comparisons have classified the helicases into three
superfamilies (SF): SFI, SFII, and SFIII (14, 19, 37). The
HCV NS3 helicase belongs to SFII, which contains eight conserved motifs
(14, 24). Motifs I (AxxGxGKS/T) and II (DExH),
known as Walker motifs A and B, respectively (44), are
responsible for binding the NTP-Mg2+ complex
(46), while motif VI (QRxGRxGR) is thought to
bind nucleic acids (11, 19) because it possesses many
basic residues (notably Arg).
The crystal structure of HCV NS3 helicase has recently been uncovered
(7, 22, 48). The reported structures shared similar global
conformation, which consisted of three domains forming a Y-shaped
configuration. The structure reported by Kim et al. is the only one
based on a cocrystallization of the helicase with a sulfate ion and a
(dU)8 oligonucleotide (22). Notably,
Kim et al. predicted that conserved motif VI (QRRGRTGR)
would not interact with the single-stranded DNA oligonucleotide as
originally expected but would be involved in ATP hydrolysis. On the
other hand, hydrophobic residue Val-432 and aromatic residue Trp-501 are associated with the (dU)8 oligonucleotide.
They also noted that His-293 and Gln-460 from motifs II and VI,
respectively, lie on opposite sides of the interdomain cleft and
referred to them as "gatekeepers." However, the importance of
gatekeepers has not been biochemically determined yet.
To decipher the link between the biochemical role and three-dimensional
structure of the important amino acid residues, this study investigated
the activities of 17 point mutation clones of NS3.
 |
MATERIALS AND METHODS |
Site-directed mutagenesis.
The plasmid 5'-1175/pET21a
(41), which contains the RNA helicase domain encompassing
aa 1175 (nucleotide [nt] 3864) to 1657 (nt 5312) cloned at the
BamHI and HindIII sites of the pET21a plasmid, was used as the target plasmid for site-directed mutagenesis. Mutants A204V, K210N, D290N, E291Q, C292A, H293A, C292A/H293D, and
R461Q were constructed using the Transformer site-directed mutagenesis
kit (Clontech) according to the manufacturer's instructions. Meanwhile, mutations were confirmed by DNA sequencing. Table
1 lists the sequences of the mutagenic
primers. The remaining mutants E291A, H293K, H293Q, T322A, T324A,
V432A, C292A/H293D/Q460H, W501A, and V432A/W501A were constructed using
recombinant PCR, with the desired mutations introduced in the internal
mutagenic primers (Table 1). The mutated forms of the BamHI
(nt 3864)-EcoRI (nt 4578) DNA fragments (for mutants E291A,
H293K, H293Q, T322A, and T324A) or the EcoRI (nt
4578)-StuI (nt 5034) DNA fragments (for mutants V432A and
W501A) were then used in place of the corresponding regions of the
parental 5'-1175/pET21a plasmid. Mutant Q460H/C292A/H293D was generated
by substituting the mutated EcoRI-StuI fragment harboring the Q460H mutation for the corresponding region of the C292A/H293D plasmid, while mutant V432A/W501A was constructed by
substituting the EcoRI-StuI DNA fragment
harboring the W501A mutation for the same region of the V432A plasmid.
To ensure that only the desired mutation was introduced, the PCR
portions were sequenced with the dideoxy DNA sequencing method.
Expression and purification of mutant proteins.
The mutant
plasmids were transformed into Escherichia coli BL21(DE3).
Expression of the plasmids was induced by adding 0.2 mM
isopropyl-
-D-thiogalactopyranoside (IPTG) at
30°C for 3 h. Purification of the proteins was performed by
using an Ni-affinity column as previously described (41).
The final eluted proteins were dialyzed in TNE buffer (20 mM Tris-HCl,
pH 7.9, 50 mM NaCl, and 1 mM EDTA) and were concentrated using
Centriprep-10 (Amicon). The purified proteins were quantified using a
bicinchoninic acid protein assay reagent (Pierce).
ATPase activity assays.
ATPase activity was assessed by
measuring the extent of [
-32P]ATP hydrolysis
as previously described (41). The reaction mixture (10 µl) contained 20 mM HEPES-KOH (pH 7.0), 2 mM dithiothreitol, 1.5 mM
MgCl2, 5 µCi of
[
-32P]ATP (3,000 Ci/mmol; Amersham), 100 µg of poly(U)/ml, 0.05 µg of wild-type or mutant helicases, and
various concentrations of cold ATP ranging from 0.067 mM to 0.8 mM. For
kinetic analysis, the reaction was carried out at room temperature for
just 5 min to constrain the reaction rate within the linear phase and
was then halted by adding EDTA to 20 mM. Reaction products were
analyzed by thin-layer chromatography. One-half microliter of the
reaction mixture was spotted onto plastic-backed polyethyleneimine
cellulose F sheets (Merck) and was developed by ascending
chromatography in 0.375 M potassium phosphate (pH 3.5) buffer. The
sheets were dried and exposed to a FUJIX imaging plate, and the
conversion rate was quantified by phosphorimager analysis (FUJIX BAS1000).
ATP binding assays.
UV cross-linking (29, 49)
was used to assess the ATP binding ability of those mutants whose
ATPase activity was undetectable. However, this is a nonequilibrium
method of measuring ATP binding. One microgram of wild-type or mutant
helicase protein and 100 µg of poly(U)/ml were premixed in 10 µl of
a buffer containing 20 mM HEPES-KOH, pH 7.5, and 5 mM
Mg(CH3CO2)2.
Then 6 µCi (2 pmol) of [
-32P]ATP (3,000 Ci/mmol; Amersham) and 181 pmol of cold ATP were added. The reaction
mixture was incubated on ice and was then irradiated using a UV
cross-linker (Stratagene) (254 nm) situated at a distance of 4 cm for 25 min. Samples were boiled in sample buffer (100 mM Tris-HCl,
pH 6.8, 2% sodium dodecyl sulfate [SDS], 20%
-mercaptoethanol,
20% glycerol, 4 mM EDTA, and 0.01% bromophenol blue) for 5 min and
were then separated by SDS-12.5% polyacrylamide gel electrophoresis
(PAGE). The gels were stained with Coomassie brilliant blue, dried, and
processed for autoradiography.
Preparation of partial dsRNA substrates.
The partial
double-stranded RNA (dsRNA) substrates were prepared by transcribing in
vitro a portion of the multiple cloning sequences of a pGEM vector
(Promega) in both orientations and then annealing these two RNA strands
(41). After in vitro transcription, the transcripts were
combined at a molar ratio of released strand (labeled) to template
strand (unlabeled) of approximately 1:10 in a solution containing 20 mM
HEPES-KOH (pH 7.6), 0.5 M NaCl, 1 mM EDTA, and 0.1% SDS. The mixture
was boiled for 10 min, transferred to 65°C for 30 min, and then
incubated at 25°C overnight. The hybridized products were mixed with
5× RNA loading dye (0.1 M Tris-HCl [pH 7.4], 20 mM EDTA, 0.5% SDS,
0.1% bromophenol blue, 0.1% xylene cyanol, and 50% glycerol) and
then subjected to electrophoresis on an 8% native polyacrylamide
(acrylamide/bisacrylamide ratio, 30:1)-1× Tris-borate-EDTA
gel. The duplex RNA band was localized by autoradiography. The gel
slice was excised, pulverized, and extracted with 0.5 M ammonium
acetate (pH 7.0)-0.1% SDS-10 mM EDTA for 2 h at 25°C. The
eluted substrate was then extracted with phenol-chloroform, ethanol
precipitated, and resuspended in storage buffer (20 mM HEPES [pH 7.6]
and 0.1 mM EDTA). The annealed product contains both 5' and 3' overhang
regions and an internal double-stranded region.
RNA binding assays.
The binding of the partial dsRNA
substrate to the HCV NS3 helicase or to the mutant proteins was
analyzed by gel mobility shift assay. One-half microgram of the
wild-type or mutant helicase protein was incubated with 1.3 pmol of
radiolabeled partial dsRNA substrate and 15 pmol of cold single release
strand in 20 µl of a helicase reaction buffer containing
nonhydrolyzable ATP-
S. The binding reaction was incubated at 37°C
for 15 min and was then terminated by adding 5× RNA loading dye
containing 0.5% Nonidet P-40 instead of SDS and was electrophoresed on
a 4% polyacrylamide (acrylamide/bisacrylamide ratio,
80:1)-1/3× Tris-borate-EDTA gel containing 5% glycerol. The
bound complexes were visualized by autoradiography (41).
RNA helicase assays.
Helicase assays were conducted by
measuring the unwinding of the radiolabeled dsRNA substrate as
previously described (41) except that, for kinetic
analysis, the reaction was performed for just 5 min to constrain the
reaction rate within the linear phase. The reaction mixture (20 µl)
contained 20 mM HEPES-KOH (pH 7.0), 2 mM dithiothreitol, 1.5 mM
MnCl2, 2.5 mM ATP, 0.1 mg of bovine serum albumin
per ml, 2 U of RNasin, 0.1 µg of wild-type or mutant helicases, and
various amounts of dsRNA substrate ranging from 0.66 pmol to 10.56 pmol. The reaction was carried out at 37°C for 5 min and was then
terminated by adding 5 µl of 5× RNA loading dye. An aliquot (12.5 µl) of each reaction was loaded onto an 8% native polyacrylamide
(acrylamide/bisacrylamide ratio, 30:1)-1× Tris-borate-EDTA gel
and electrophoresed. The gel was dried and autoradiographed. The ratio
of single-stranded products to double-stranded substrates was
quantified by phosphorimager analysis (FUJIX BAS1000).
 |
RESULTS |
Mutation, expression, and purification of HCV helicase
proteins.
Like many other SFII helicases, the HCV NS3 helicase
contains several conserved motifs. This work investigates the roles of conserved motifs I, II, III, and VI and the two possible
RNA-interacting residues, Val-432 and Trp-501, in ATP hydrolysis, RNA
binding, and RNA helicase activities. A total of 17 mutants were
constructed using site-directed mutagenesis. Figure
1A illustrates the mutated positions and
the amino acids replaced. The wild type and the mutant clones were
expressed in an E. coli pET expression system, and the
recombinant proteins were purified using the Ni-agarose affinity
column. Figure 1B illustrates the SDS-PAGE results for 2 µg of each
of the purified proteins. The estimated molecular mass of the wild-type
NS3 helicase or its mutant proteins is approximately 56 kDa. The data
revealed that all these proteins had similar purities (ranging from 80 to 88%).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Site-directed mutagenesis of the HCV NS3 helicase
domain. (A) Summary of all mutant clones. The top line sequences
represent conserved motifs I, II, III, and VI, respectively, of HCV NS3
helicase. The amino acid residue replacements are shown below the
arrows. (B) Purities of mutant proteins. The wild-type and mutant
proteins were expressed in E. coli and purified as
described in Materials and Methods. Two micrograms of each of the
purified proteins was resolved by SDS-12.5% PAGE and stained with
Coomassie brilliant blue. WT denotes the wild-type helicase protein.
|
|
ATPase activity of helicase mutants.
ATPase activity was
measured in the presence of poly(U) to stimulate the ATP hydrolysis
activity of HCV NS3 (40, 41). Enzymatic activity was
measured kinetically and expressed as
kcat/Km, determined by varying the concentration of ATP substrate. All mutant
proteins displayed a degree of reduced ATPase activity when compared to
the wild-type protein (Table 2).
According to the data herein, mutations at motifs I and II (Walker
motifs A and B, respectively) affected ATPase activity
differently.
While the A204V mutation did not alter ATPase activity,
the K210N,
D290N, and E291Q mutant proteins completely lost ATPase
activity,
suggesting that the Lys-210 residue of motif I
(AxxGxGK
210ST)
and the Asp-290 and Glu-291
residues of motif II
(D
290E
291CH)
were crucial
to ATPase activity. Yet, replacing Glu-291 (E291A)
with Ala only
slightly affected ATPase activity. Replacing the
third residue of the
DEC
292H motif (C292A) with Ala reduced ATPase
activity to nearly half that of the wild-type protein. The fourth
residue of the DECH
293 motif was also involved in
ATP hydrolysis,
as replacing His-293 (H293A or H293Q) with Ala or Gln
reduced
ATPase activity to 6 or 29%, respectively, whereas replacing
His-293
(H293K) with Lys reduced it to 44% of wild-type protein
activity.
Double mutation at the third and fourth residues,
C292A/H293D,
further lowered the ATPase activity to undetectable
levels. The
results, collectively, indicate that all four residues of
motif
II are involved in ATP hydrolysis and that Asp-290, Glu-291, and
His-293 are particularly crucial to ATPase
activity.
As hypothesized, the gatekeepers are His-293 of the
DECH
293 motif and Gln-460 of the
Q
460RRGRTGR motif, found in the HCV NS3
helicase
(
22), or the Asp residue of the DEA
D motif and
the
His residue of motif VI (
HRIGRGGR),
found in eIF4A (gatekeepers
are underlined) (
23). Since
the double mutation clone C292A/H293D
contained an Asp at position 293, a His was substituted for the
Q460 therein to restore the gatekeeper
relationship, yielding
the triple mutation clone C292A/H293D/Q460H. The
ATPase activity
of this triple mutation clone was not restored, however
(Table
2), thus demonstrating that gatekeepers cannot be replaced with
those from different
subgroups.
Motif III contains a conserved T
322ATPP sequence
and is thought to act as a hinge, connecting domains I and II.
Substituting
Ala for Thr-322 (T322A) or the Thr-324 residue (T324A)
reduced
ATPase activity dramatically (30 and 16%, respectively, of
activity
shown by the wild-type protein). Surprisingly, mutation of the
Arg-461 residue of motif VI to Gln (R461Q) also significantly
influenced ATPase activity (7% of that shown by the wild-type
protein). Singly mutating the putative RNA-interacting residues
(Val-432 or Trp-501) to Ala (V432A or W501) only slightly affected
ATPase activity, but simultaneously mutating both residues
(V432A/W501A)
significantly reduced activity (8% of that shown by the
wild-type
protein).
To further investigate why mutants K210N, D290N, E291Q,
C292A/H293D, and C292A/H293D/Q460H displayed no ATPase
activity, their
ATP binding abilities were examined using a UV
cross-linking method
(
29,
49). The purified proteins were
incubated with poly(U)
before adding the
[

-
32P]ATP and an excess amount, in relation
to the enzyme, of cold
ATP. The mixtures were subsequently cross-linked
via UV light.
Protein that displayed ATP binding activity would be
covalently
bound to ATP and became radiolabeled. The wild-type helicase
protein
was efficiently labeled, as illustrated in Fig.
2. No radioactivity
was observed,
however, if the incubation was not exposed to UV
light or if the
incubation used a control bovine serum albumin
protein instead of the
helicase protein, thus revealing a specific
binding of ATP to the
helicase protein. As for the mutant proteins,
K210N and D290N
completely lost their ATP binding ability, indicating
their loss of
ATPase activity, yet the other three mutant clones,
C292A/H293D,
C292A/H292D/Q460H, and E291Q, still retained various
degrees of ATP
binding ability. Other mechanisms must therefore
exist, which act
synergistically to account for the complete loss
of ATPase activity.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 2.
ATP binding activity of the wild type and some mutant
helicase proteins. One microgram of the wild-type or mutant helicase
proteins was incubated with [ -32P]ATP in the presence
of poly(U) and was UV cross-linked [WT(-UV)] as described in
Materials and Methods. Samples were separated by SDS-12.5% PAGE.
Following electrophoresis, the gels were stained with Coomassie
brilliant blue, dried, and processed for autoradiography. WT, wild-type
helicase protein; BSA, bovine serum albumin.
|
|
RNA binding activity of helicase mutants.
RNA binding
activity was measured by gel mobility shift assay. As illustrated in
Fig. 3, all mutant proteins but R461Q,
W501A, and V432A/W501A bound RNA as efficiently as the wild-type
protein did. Mutants A204V, K210N, H293K, H293Q, and T322A exhibited
even slightly higher RNA binding activity than the wild-type protein. Notably, the V432A mutant exhibited virtually normal RNA binding activity. The W501A mutant retained only residual RNA binding activity,
but the double mutation clone V432A/W501A almost completely lost RNA
binding activity (Fig. 3). These results suggested that Trp-501 was
crucial to RNA binding, whereas Val-432 might play an auxiliary role.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 3.
RNA binding activity of wild-type and mutant helicase
proteins. The wild-type or mutant helicase proteins, cold release
strand RNA, and labeled dsRNA substrate were incubated as described in
Materials and Methods. The reaction mixtures were electrophoresed by
native PAGE and were processed for autoradiography. WT denotes the
wild-type helicase protein.
|
|
RNA helicase activity of helicase mutants.
The helicase
activity of all mutant proteins was measured and expressed as
kcat/Km,
determined by varying the concentration of dsRNA substrate. Results
given in Table 2 indicate that the helicase activity was completely
abolished in two types of mutants: namely, those whose ATPase activity
was completely lost (for example, K210N, D290N, E291Q, C292A/H293D, and
C292A/H293D/Q460H) and those whose RNA binding activity was
dramatically reduced (for example, R461Q, W501A, and V432A/W501A). The
helicase activity of other mutants was only moderately affected,
including mutants whose ATPase activity was severely reduced but not
completely abolished (for example, H293A and T324A) (see below).
Relationship of ATPase activity and RNA helicase
activity.
To correlate the ATPase activity and RNA helicase
activity of these mutant proteins, both activities were translated into their ratios relative to wild-type protein activity (Table 2). The
relationship between RNA helicase activity and ATPase activity is
presented in Fig. 4. The unwinding of
dsRNA is an ATP-dependent process, and ATP hydrolysis is a prerequisite
for RNA helicase activity. Therefore, as anticipated, mutants with
abolished ATPase activity (such as K210N, D290N, E291Q, C292A/H293D,
and C292A/H293D/Q460H) would impede RNA helicase activity.
Unexpectedly, some mutants (for example, H293A and T324A) which
exhibited ATPase activity as low as 6 to 16% of that exhibited by the
wild-type protein still displayed sufficient RNA helicase activity (75 and 62%, respectively) (Fig. 4). These analytical results suggest that a low ATPase activity threshold (e.g., 6%) is sufficient for the present RNA helicase assay. Accordingly, the loss of RNA helicase activity in mutants R461Q, W501A, and V432A/W501A is probably caused by
reduced RNA binding ability or is a synergistic effect of both reduced
ATPase and reduced RNA binding activities.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
Relationship of ATPase activity and RNA helicase
activity. Both ATPase activity and RNA helicase activity of all mutant
proteins were translated into ratios relative to activity of the
wild-type (WT) helicase protein (data shown in Table 2). The
relationship was then plotted as the RNA helicase activity versus
ATPase activity.
|
|
 |
DISCUSSION |
The structure of domains I and II of the HCV NS3 helicase displays
a fold similar to that of domains 1A and 2A, respectively, of the PcrA
DNA helicase, whose structure was recently solved by cocrystallizing
the protein with a nonhydrolyzable ATP analog and a magnesium ion
(43). In comparing the PcrA DNA helicase structure with
those reported structures for the HCV NS3 helicase (7, 22,
48), some different aspects among these models are noted. The
results of this study may thus provide clues to elucidating the
relationship between the function and the three-dimensional structure
of each critical amino acid residue.
Residues that influence ATP hydrolysis.
The amino acids in the
conserved Walker A motif (Lys-210) and Walker B motif (Asp-290,
Glu-291, and His-293) are crucial to ATP hydrolysis, as predicted. This
investigation additionally identified other residues not contained in
Walker A and B motifs but also vital to ATPase activity, for example,
Gln-460, Thr-322, Thr-324, and Arg-461. To function in ATP hydrolysis,
all of these residues except Arg-461 are conformationally proximal to
NTP (Fig. 5).

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 5.
Locations of the important amino acid residues in the
three-dimensional conformation. The structure of HCV NS3 helicase was
based on that determined by Kim et al. (22) using Protein
Data Bank (PDB) accession code 1A1V. The important residues
identified herein and the Arg-464/Arg-467 previously demonstrated
(21, 22, 43) are emphasized by being represented in stick
format, while the sulfate ion is represented in Corey-Pauling-Koltun
(CPK) format. Residues His-293 and Gln-460 are located in
domains I and II, respectively. It is hypothesized that the amine group
of the histidine ring of His-293 formed a hydrogen bond with the
carbonyl oxygen of the side chain of Gln-460. Residue Arg-461 is
located in the interior of domain II. The inset indicates that the
Arg-461 can form hydrogen bonds with Asp-412 and Asp-427, which are
located at conserved motif V. These figures were drawn using
InsightII.
|
|
Previous studies have demonstrated that the conserved lysine residue in
Walker A (GxG
KS) is involved in binding to the

phosphate
of NTP (
39,
43), while the conserved Asp-290
residue in Walker
B (
DECH), structurally proximal to the
Walker A motif, can bind
Mg
2+ and assists in
orienting the Mg
2+-ATP substrate for ATP
hydrolysis (
1,
32,
47). Mutations
of these two residues
consequently completely impeded ATP binding
and ATPase activities (Fig.
2 and Table
2).
The conserved Glu-291 residue of motif II (D
ExH) generally
serves as a Lewis base, activating the attacking water molecule
during
the hydrolysis of ATP, as previously demonstrated in PcrA
DNA helicase
(
43). The negatively charged carboxylate side chain
of
Glu-291 might accelerate the release of the hydrolysis product,
P
i. Interestingly, replacing Glu-291 (E291Q) with Gln did
not
alter ATP binding activity but completely inhibited ATPase activity
(Fig.
2 and Table
2). We reasoned that substituting Gln for Glu
might
cause loss of the Lewis base function or/and strengthen
binding rather
than releasing the hydrolysis product, P
i. Substitution
of
Ala for the Glu-291 (E291A), however, did not cause a significant
reduction in ATPase activity. We suspect that water molecules
will
occupy the side chain position of the Glu-291 in mutant E291A
and still
serve as a Lewis
base.
The side chains of Glu-291, His-293, and Thr-322 form a network
of hydrogen bonds in the absence of substrate (
48). Thus,
when either residue was mutated (E291K, H293A, H293K, H293Q,
C292A/H293D,
and T322A) or the interactions between motifs I,
II, and III were
disrupted, the ATP binding and hydrolysis would then
be affected.
Moreover, the crystal structure (
22) revealed
a close proximity
(~4 Å) of His-293 in motif II and Gln-460 in motif
VI (Fig.
5).
This pair of residues was predicted to modulate the
opening/closure
switch of domains I and II upon ATP binding and served
as gatekeepers
(
22). Another gatekeeper pair is the
DEAD/HRxGR combination
found in the DEAD helicase subgroup (for
example, eIF4A) (
14).
We hypothesized that the amine group
of the histidine ring of
His-293 might form a hydrogen bond with the
carbonyl oxygen of
the side chain of Gln-460. Because the closed form
of PcrA is
stabilized by direct contact of the

phosphate of ATP
with Gln-254
and two Arg residues, Arg-287 and Arg-610
(
43), which correspond
to Arg-464 and Arg-467,
respectively, in motif VI of the HCV NS3
helicase (Fig.
5), the
interaction of His-293 and Gln-460 found
in the latter might be
predicted to facilitate the formation of
hydrogen bonds between
Arg-464/Arg-467 and ATP, thus producing
a more stable closure
conformation. However, even if Gln-460 of
the double mutation clone
C292A/H293D was further mutated to His
(the triple mutation clone
C292A/H293D/Q460H), such that the hydrogen
bond might be restored
between Asp-293 and His-460, ATPase activity
was not restored (Table
2). Such a phenomenon was also observed
in eIF4A and Prp2 helicase
mutants, the gatekeepers of which were
found to be not exchangeable
between two different SFII subgroups
(
10,
34). All these
results thus indicate that the network
or microenvironment
surrounding the key residues will contribute
to the overall
conformation, which is probably more important
to the enzymatic
activities.
The importance of Thr-322 and Thr-324 of motif III, which connects
domains I and II, in ATPase activity most likely resulted
from their
roles in modulating the opening and closure of the
ATP binding cleft
between these two domains (
7), whereas the
role of Arg-461
is obscure. Because Arg-461 is located in the
interior of domain II
(Fig.
5) and forms hydrogen bonds with Asp-412
and Asp-427 (Fig.
5,
inset) (
22), it is unlikely that Arg-461
directly contacts
ATP, but it is likelier that it holds a proper
conformation for domain
II. Thus, Arg-461 probably influences
ATPase activity in an indirect
manner. Finally, it was also observed
herein that a single mutation at
the RNA-interacting residues,
Val-432 or Trp-501, did not markedly
affect ATP hydrolysis activity,
whereas simultaneous mutation at both
residues severely reduced
ATP hydrolysis activity (Table
2). Unlike
mutant V432A or W501A,
the V432A/W501A mutant almost totally lost RNA
binding activity
(Fig.
3). The experimental results thus suggest that
the ATPase
activity of HCV NS3 helicase is strongly stimulated by the
presence
of RNA, which agrees with previous analysis of the ATPase
activity
of the wild-type helicase protein in the presence or absence
of
polynucleotide (
12,
16,
40,
41,
45).
Residues that influence RNA binding.
The crystal
structures determined by Cho et al. and Yao et al. located the
single-stranded RNA (ssRNA) in a channel formed by the interdomain
cleft between domains I and II (7, 48), whereas that
determined by Kim et al. located the oligonucleotide in a groove
between the first two domains and the third (22). The
latter thus resembles that of PcrA DNA helicase (43). The mutagenesis data described herein demonstrated that Trp-501 was crucial
for RNA binding, thus supporting the model proposed by Kim et al.
(22). But our data demonstrated that Val-432, one of the
"bookends" for the ssRNA binding proposed by the model, might play
only a minor role. Notably, however, simultaneous mutation at Val-432
and Trp-501 synergistically degraded RNA binding activity. The role of
Val-432 determined in this study is also different from that reported
by other groups using full-length NS3 (33, 35). The
discrepancy is not clear but may be due to different proteins (helicase
domain versus full-length NS3) and assay systems used in different laboratories.
Mutation of Arg-461 also reduced RNA binding activity, though not
dramatically. This finding contradicts the results reported
by Kim et
al. (
21) but is consistent with more recent results
published by Kwong et al. (
26). In support of our
findings,
the mutation at the same position of vaccinia virus NPH-II
also
decreased RNA binding (
15). As discussed above,
Arg-461 is located
in the interior of domain II and forms a hydrogen
bond with Asp-412
and Asp-427. Lin and Kim recently reported that
Thr-411, right
next to Asp-412, was one of the important residues to
bind ssRNA
(
30). Thus, the decrease of RNA binding in the
R461Q mutant
may be indirectly caused by the interruption of the
interaction
between Arg-461 and Asp-412, which in turn leads to a
conformational
change in the polynucleotide binding channel and a loss
of interaction
between Thr-411 and
ssRNA.
Factors that affect RNA helicase activity and the
implications.
Unwinding of RNA is an ATP-dependent process which
requires ATP binding, ATP hydrolysis, and RNA binding. It is reasonable to hypothesize that the mutants whose ATPase activity is abolished will
also impede RNA helicase activity. Mutants K210N, D290N, E291Q,
C292A/H293D, and C292A/H293D/Q460H indeed followed this rule (Table 2).
Surprisingly, however, some mutants with fairly low ATPase activity (6 to 16% of the wild-type helicase) still exhibited sufficiently high
RNA helicase activity (for example, H293A and T324A). Similar phenomena
were observed in previous mutational studies (21, 30).
These results thus suggest that the ATPase activity required for RNA
unwinding may be minimal. On the contrary, reduction of RNA binding
activity markedly influenced RNA helicase activity, e.g., R461Q and
W501A (Table 2). Based on these findings, we suggest that interfering
with RNA binding activity rather than interfering with ATPase activity
should be considered more in designing antiviral therapeutics for
hepatitis C.
 |
ACKNOWLEDGMENTS |
C.-L. Tai and W.-C. Pan contributed equally to this work.
We are indebted to Pei-Jer Chen and Ted Knoy for critical reading of
the manuscript.
This work was supported in part by grants NSC 89-2315-B-002-014-MH and
NSC 89-2321-B002-002 from National Science Council of the Republic of
China and in part by financial support from the Liver Disease
Prevention and Treatment Research Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Hepatitis
Research Center, National Taiwan University Hospital, 7, Chung-Shan S. Rd., Taipei 100, Taiwan. Phone: 886-2-23123456, ext. 7503. Fax:
886-2-23825962. E-mail: lihhwa{at}ha.mc.ntu.edu.tw.
 |
REFERENCES |
| 1.
|
Black, M. E., and D. E. Hruby.
1992.
Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium binding.
J. Biol. Chem.
267:6801-6806[Abstract/Free Full Text].
|
| 2.
|
Brillanti, S.,
J. Garson,
M. Foli,
K. Whitby,
R. Deaville,
C. Masci,
M. Miglioli, and L. Barbara.
1994.
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.
Gastroenterology
107:812-817[Medline].
|
| 3.
|
Brillanti, S.,
M. Miglioli, and L. Barbara.
1995.
Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
J. Hepatol.
23:13-15.
|
| 4.
|
Chamberlain, R. W.,
N. Adams,
A. A. Saeed,
P. Simmonds, and R. M. Elliott.
1997.
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East.
J. Gen. Virol.
78:1341-1347[Abstract].
|
| 5.
|
Chemello, L.,
L. Cavalletto,
E. Bernardinello,
M. Guido,
P. Pontisso, and A. Alberti.
1995.
The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.
J. Hepatol.
23:8-12.
|
| 6.
|
Chen, D. S.,
G. C. Kuo,
J. L. Sung,
M. Y. Lai,
J. C. Sheu,
P. J. Chen,
P. M. Yang,
H. M. Hsu,
M. H. Chang,
C. J. Chen, et al.
1990.
Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.
J. Infect. Dis.
162:817-822[Medline].
|
| 7.
|
Cho, H. S.,
N. C. Ha,
L. W. Kang,
K. M. Chung,
S. H. Back,
S. K. Jang, and B. H. Oh.
1998.
Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA.
J. Biol. Chem.
273:15045-15052[Abstract/Free Full Text].
|
| 8.
|
Choo, Q. L.,
G. Kuo,
A. J. Weiner,
L. R. Overby,
D. W. Bradley, and M. Houghton.
1989.
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.
Science
244:359-362[Abstract/Free Full Text].
|
| 9.
|
Di Bisceglie, A. M.
1997.
Hepatitis C and hepatocellular carcinoma.
Hepatology
26:34S-38S[CrossRef][Medline].
|
| 10.
|
Edwalds-Gilbert, G.,
D. H. Kim,
S. H. Kim,
Y. H. Tseng,
Y. Yu, and R. J. Lin.
2000.
Dominant negative mutants of the yeast splicing factor Prp2 map to a putative cleft region in the helicase domain of DExD/H-box proteins.
RNA
6:1106-1119[Abstract].
|
| 11.
|
Fuller-Pace, F. V.
1994.
RNA helicase: modulators of RNA structure.
Trends Cell Biol.
4:271-274[CrossRef][Medline].
|
| 12.
|
Gallinari, P.,
D. Brennan,
C. Nardi,
M. Brunetti,
L. Tomei,
C. Steinkuhler, and R. De Francesco.
1998.
Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus.
J. Virol.
72:6758-6769[Abstract/Free Full Text].
|
| 13.
|
Gorbalenya, A. E.,
E. V. Koonin,
A. P. Donchenko, and V. M. Blinov.
1988.
A novel superfamily of nucleoside triphosphate-binding motif containing proteins which are probably involved in duplex unwinding in DNA and RNA replication and recombination.
FEBS Lett.
235:16-24[CrossRef][Medline].
|
| 14.
|
Gorbalenya, A. E.,
E. V. Koonin,
A. P. Donchenko, and V. M. Blinov.
1989.
Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes.
Nucleic Acids Res.
17:4713-4730[Abstract/Free Full Text].
|
| 15.
|
Gross, C. H., and S. Shuman.
1996.
The QRxGRxGRxxxG motif of the vaccinia virus DExH box RNA helicase NPH-II is required for ATP hydrolysis and RNA unwinding but not for RNA binding.
J. Virol.
70:1706-1713[Abstract].
|
| 16.
|
Hesson, T.,
A. Mannarino, and M. Cable.
2000.
Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates.
Biochemistry
39:2619-2625[CrossRef][Medline].
|
| 17.
|
Hoofnagle, J. H.
1997.
Hepatitis C: the clinical spectrum of disease.
Hepatology
26:15S-20S[CrossRef][Medline].
|
| 18.
|
Jin, L., and D. L. Peterson.
1995.
Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase.
Arch. Biochem. Biophys.
323:47-53[CrossRef][Medline].
|
| 19.
|
Kadare, G., and A. L. Haenni.
1997.
Virus-encoded RNA helicases.
J. Virol.
71:2583-2590[Medline].
|
| 20.
|
Kim, D. W.,
Y. Gwack,
J. H. Han, and J. Choe.
1995.
C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity.
Biochem. Biophys. Res. Commun.
215:160-166[CrossRef][Medline].
|
| 21.
|
Kim, D. W.,
J. Kim,
Y. Gwack,
J. H. Han, and J. Choe.
1997.
Mutational analysis of the hepatitis C virus RNA helicase.
J. Virol.
71:9400-9409[Abstract].
|
| 22.
|
Kim, J. L.,
K. A. Morgenstern,
J. P. Griffith,
M. D. Dwyer,
J. A. Thomson,
M. A. Murcko,
C. Lin, and P. R. Caron.
1998.
Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding.
Structure
6:89-100[Medline].
|
| 23.
|
Koonin, E. V., and V. V. Dolja.
1993.
Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences.
Crit. Rev. Biochem. Mol. Biol.
28:375-430[Medline].
|
| 24.
|
Korolev, S.,
N. Yao,
T. M. Lohman,
P. C. Weber, and G. Waksman.
1998.
Comparisons between the structures of HCV and Rep helicases reveal structural similarities between SF1 and SF2 super-families of helicases.
Protein Sci.
7:605-610[Medline].
|
| 25.
|
Kuo, G.,
Q. L. Choo,
H. J. Alter,
G. L. Gitnick,
A. G. Redeker,
R. H. Purcell,
T. Miyamura,
J. L. Dienstag,
M. J. Alter,
C. E. Stevens, et al.
1989.
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.
Science
244:362-364[Abstract/Free Full Text].
|
| 26.
|
Kwong, A. D.,
J. L. Kim, and C. Lin.
2000.
Structure and function of hepatitis C virus NS3 helicase.
Curr. Top. Microbiol. Immunol.
242:171-196[Medline].
|
| 27.
|
Kwong, A. D.,
J. L. Kim,
G. Rao,
D. Lipovsek, and S. A. Raybuck.
1999.
Hepatitis C virus NS3/4A protease.
Antivir. Res.
41:67-84[Medline].
|
| 28.
|
Lai, M. Y.,
J. H. Kao,
P. M. Yang,
J. T. Wang,
P. J. Chen,
K. W. Chan,
J. S. Chu, and D. S. Chen.
1996.
Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.
Gastroenterology
111:1307-1312[CrossRef][Medline].
|
| 29.
|
Laín, S.,
M. T. Martín,
J. L. Riechmann, and J. A. García.
1991.
Novel catalytic activity associated with positive-strand RNA virus infection: nucleic acid-stimulated ATPase activity of the plum pox potyvirus helicaselike protein.
J. Virol.
65:1-6[Abstract/Free Full Text].
|
| 30.
|
Lin, C., and J. L. Kim.
1999.
Structure-based mutagenesis study of hepatitis C virus NS3 helicase.
J. Virol.
73:8798-8807[Abstract/Free Full Text].
|
| 31.
|
Miller, R. H., and R. H. Purcell.
1990.
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups.
Proc. Natl. Acad. Sci. USA
87:2057-2061[Abstract/Free Full Text].
|
| 32.
|
Pai, E. F.,
U. Krengel,
G. A. Petsko,
R. S. Goody,
W. Kabsch, and A. Wittinghofer.
1990.
Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 Å resolution: implications for the mechanism of GTP hydrolysis.
EMBO J.
9:2351-2359[Medline].
|
| 33.
|
Paolini, C.,
A. Lahm,
R. De Francesco, and P. Gallinari.
2000.
Mutational analysis of hepatitis C virus NS3-associated helicase.
J. Gen. Virol.
81:1649-1658[Abstract/Free Full Text].
|
| 34.
|
Pause, A., and N. Sonenberg.
1992.
Mutational analysis of a DEAD box RNA helicase: the mammalian translation initiation factor eIF-4A.
EMBO J.
11:2643-2654[Medline].
|
| 35.
|
Preugschat, F.,
D. P. Danger,
L. H. Carter III,
R. G. Davis, and D. J. Porter.
2000.
Kinetic analysis of the effects of mutagenesis of W501 and V432 of the hepatitis C virus NS3 helicase domain on ATPase and strand-separating activity.
Biochemistry
39:5174-5183[CrossRef][Medline].
|
| 36.
|
Saito, I.,
T. Miyamura,
A. Ohbayashi,
H. Harada,
T. Katayama,
S. Kikuchi,
Y. Watanabe,
S. Koi,
M. Onji,
Y. Ohta,
Q. L. Choo,
M. Houghton, and G. Kuo.
1990.
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.
Proc. Natl. Acad. Sci. USA
87:6547-6549[Abstract/Free Full Text].
|
| 37.
|
Schmid, S. R., and P. Linder.
1992.
D-E-A-D protein family of putative RNA helicases.
Mol. Microbiol.
6:283-291[Medline].
|
| 38.
|
Seeff, L. B.
1997.
Natural history of hepatitis C.
Hepatology
26:21S-28S[CrossRef][Medline].
|
| 39.
|
Subramanya, H. S.,
L. E. Bird,
J. A. Brannigan, and D. B. Wigley.
1996.
Crystal structure of a DExx box DNA helicase.
Nature
384:379-383[CrossRef][Medline].
|
| 40.
|
Suzich, J. A.,
J. K. Tamura,
F. Palmer-Hill,
P. Warrener,
A. Grakoui,
C. M. Rice,
S. M. Feinstone, and M. S. Collett.
1993.
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes.
J. Virol.
67:6152-6158[Abstract/Free Full Text].
|
| 41.
|
Tai, C.-L.,
W.-K. Chi,
D.-S. Chen, and L.-H. Hwang.
1996.
The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3).
J. Virol.
70:8477-8484[Abstract].
|
| 42.
|
Tong, M. J.,
N. S. el-Farra,
A. R. Reikes, and R. L. Co.
1995.
Clinical outcomes after transfusion-associated hepatitis C.
N. Engl. J. Med.
332:1463-1466[Abstract/Free Full Text].
|
| 43.
|
Velankar, S. S.,
P. Soultanas,
M. S. Dillingham,
H. S. Subramanya, and D. B. Wigley.
1999.
Crystal structures of complexes of PcrA DNA helicase with a DNA substrate indicate an inchworm mechanism.
Cell
97:75-84[CrossRef][Medline].
|
| 44.
|
Walker, J. E.,
M. Saraste,
M. J. Runswick, and N. J. Gay.
1982.
Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.
EMBO J.
1:945-951[Medline].
|
| 45.
|
Wardell, A. D.,
W. Errington,
G. Ciaramella,
J. Merson, and M. J. McGarvey.
1999.
Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein.
J. Gen. Virol.
80:701-709[Abstract].
|
| 46.
|
Wittinghofer, A., and E. F. Pai.
1991.
The structure of Ras protein: a model for a universal molecular switch.
Trends Biochem. Sci.
16:382-387[CrossRef][Medline].
|
| 47.
|
Yan, H. G., and M. D. Tsai.
1991.
Mechanism of adenylate kinase. Demonstration of a functional relationship between aspartate 93 and Mg2+ by site-directed mutagenesis and proton, phosphorus-31, and magnesium-25 NMR.
Biochemistry
30:5539-5546[CrossRef][Medline].
|
| 48.
|
Yao, N.,
T. Hesson,
M. Cable,
Z. Hong,
A. D. Kwong,
H. V. Le, and P. C. Weber.
1997.
Structure of the hepatitis C virus RNA helicase domain.
Nat. Struct. Biol.
4:463-467[CrossRef][Medline].
|
| 49.
|
Yue, V. T., and P. R. Schimmel.
1977.
Direct and specific photochemical cross-linking of adenosine 5'-triphosphate to an aminoacyl-tRNA synthetase.
Biochemistry
16:4678-4684[CrossRef][Medline].
|
Journal of Virology, September 2001, p. 8289-8297, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.8289-8297.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Roy, P.
(2008). Bluetongue virus: dissection of the polymerase complex. J. Gen. Virol.
89: 1789-1804
[Abstract]
[Full Text]
-
Ma, Y., Yates, J., Liang, Y., Lemon, S. M., Yi, M.
(2008). NS3 Helicase Domains Involved in Infectious Intracellular Hepatitis C Virus Particle Assembly. J. Virol.
82: 7624-7639
[Abstract]
[Full Text]
-
Beran, R. K. F., Serebrov, V., Pyle, A. M.
(2007). The Serine Protease Domain of Hepatitis C Viral NS3 Activates RNA Helicase Activity by Promoting the Binding of RNA Substrate. J. Biol. Chem.
282: 34913-34920
[Abstract]
[Full Text]
-
Hodges, L. D., Vergunst, A. C., Neal-McKinney, J., den Dulk-Ras, A., Moyer, D. M., Hooykaas, P. J. J., Ream, W.
(2006). Agrobacterium rhizogenes GALLS Protein Contains Domains for ATP Binding, Nuclear Localization, and Type IV Secretion. J. Bacteriol.
188: 8222-8230
[Abstract]
[Full Text]
-
Durr, H., Flaus, A., Owen-Hughes, T., Hopfner, K.-P.
(2006). Snf2 family ATPases and DExx box helicases: differences and unifying concepts from high-resolution crystal structures. Nucleic Acids Res
34: 4160-4167
[Abstract]
[Full Text]
-
Lam, A. M. I., Frick, D. N.
(2006). Hepatitis C Virus Subgenomic Replicon Requires an Active NS3 RNA Helicase. J. Virol.
80: 404-411
[Abstract]
[Full Text]
-
Wang, X., Lee, W.-M., Watanabe, T., Schwartz, M., Janda, M., Ahlquist, P.
(2005). Brome Mosaic Virus 1a Nucleoside Triphosphatase/Helicase Domain Plays Crucial Roles in Recruiting RNA Replication Templates. J. Virol.
79: 13747-13758
[Abstract]
[Full Text]
-
Guo, R.-b., Rigolet, P., Zargarian, L., Fermandjian, S., Xi, X. G.
(2005). Structural and functional characterizations reveal the importance of a zinc binding domain in Bloom's syndrome helicase. Nucleic Acids Res
33: 3109-3124
[Abstract]
[Full Text]
-
Frick, D. N., Rypma, R. S., Lam, A. M. I., Frenz, C. M.
(2004). Electrostatic analysis of the hepatitis C virus NS3 helicase reveals both active and allosteric site locations. Nucleic Acids Res
32: 5519-5528
[Abstract]
[Full Text]
-
Prabhu, R., Khalap, N., Burioni, R., Clementi, M., Garry, R. F., Dash, S.
(2004). Inhibition of Hepatitis C Virus Nonstructural Protein, Helicase Activity, and Viral Replication by a Recombinant Human Antibody Clone. Am. J. Pathol.
165: 1163-1173
[Abstract]
[Full Text]
-
Perriman, R., Barta, I., Voeltz, G. K., Abelson, J., Ares, M. Jr.
(2003). ATP requirement for Prp5p function is determined by Cus2p and the structure of U2 small nuclear RNA. Proc. Natl. Acad. Sci. USA
100: 13857-13862
[Abstract]
[Full Text]
-
Lam, A. M. I., Keeney, D., Frick, D. N.
(2003). Two Novel Conserved Motifs in the Hepatitis C Virus NS3 Protein Critical for Helicase Action. J. Biol. Chem.
278: 44514-44524
[Abstract]
[Full Text]
-
Kar, A. K., Roy, P.
(2003). Defining the Structure-Function Relationships of Bluetongue Virus Helicase Protein VP6. J. Virol.
77: 11347-11356
[Abstract]
[Full Text]
-
Vlot, A. C., Laros, S. M., Bol, J. F.
(2003). Coordinate Replication of Alfalfa Mosaic Virus RNAs 1 and 2 Involves cis- and trans-Acting Functions of the Encoded Helicase-Like and Polymerase-Like Domains. J. Virol.
77: 10790-10798
[Abstract]
[Full Text]
-
Kyono, K., Miyashiro, M., Taguchi, I.
(2003). Characterization of ATPase Activity of a Hepatitis C Virus NS3 Helicase Domain, and Analysis Involving Mercuric Reagents. J Biochem
134: 505-511
[Abstract]
[Full Text]
-
Foy, E., Li, K., Wang, C., Sumpter, R. Jr., Ikeda, M., Lemon, S. M., Gale, M. Jr.
(2003). Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease. Science
300: 1145-1148
[Abstract]
[Full Text]
-
Lam, A. M. I., Keeney, D., Eckert, P. Q., Frick, D. N.
(2003). Hepatitis C Virus NS3 ATPases/Helicases from Different Genotypes Exhibit Variations in Enzymatic Properties. J. Virol.
77: 3950-3961
[Abstract]
[Full Text]
-
Kim, J. W., Seo, M. Y., Shelat, A., Kim, C. S., Kwon, T. W., Lu, H.-h., Moustakas, D. T., Sun, J., Han, J. H.
(2002). Structurally Conserved Amino Acid W501 Is Required for RNA Helicase Activity but Is Not Essential for DNA Helicase Activity of Hepatitis C Virus NS3 Protein. J. Virol.
77: 571-582
[Abstract]
[Full Text]